Titre :
  • Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.
Auteur : André, Marie Josèphe ; Baudoux, Etienne ; Bron, Dominique ; Canon, Jean-Luc ; D'Hondt, Véronique ; Fassotte, Marie-France ; D'Hondt, Lionel ; Fillet, Georges ; Humblet, Yves ; Jerusalem, Guy ; Vermeulen, Philippe ; Symann, Michel ; Beguin, Yves
Informations sur la publication : Transfusion, 43, 1, (page 50-57)
Statut de publication : Publié, 2003-01
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- therapy
Female
Filgrastim -- pharmacology
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation -- adverse effects
Humans
Leukapheresis
Lymphoma -- therapy
Male
Middle Aged
Multiple Myeloma -- therapy
Transplantation, Autologous
Note : Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0041-1132 
info:pii/trf273
info:pmid/12519430